Scientists crack the code on failed platelet transfusions
NCT ID NCT05399693
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 50 adults with severe low platelet counts who needed platelet transfusions. Researchers wanted to understand why some patients stop responding to these life-saving transfusions. They focused on antibodies that attack the donor platelets, aiming to find better ways to match transfusions in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLATELET TRANSFUSION REFRACTORINESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut de cancérologie Strasbourg Europe
Strasbourg, France